FDA Fast Tracks Keryx Immune-System Cancer Drug; Shares Rise - Wall Street Journal Print
Wall Street JournalThe stock has soared this year due to progress on its renal-disease drug, rising more than tenfold. US-traded shares in Keryx's Canadian partner Aeterna ...Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the

... read more